It is probably a squamous cell carcinoma. Please see a dermatologist and have it biopsied.' Dr Brown also urged the public to take preventative steps to avoid the disease. ‘You can prevent ...

The approvals were based on results from a phase 2 trial and a phase 3 trial. The US Food and Drug Administration (FDA) has approved the PD-1 inhibitor penpulimab-kcqx for 2 indications ...

A retrospective analysis comparing cabozantinib (Cabometyx) plus nivolumab (Opdivo; C+N) with lenvatinib (Lenvima) plus pembrolizumab (Keytruda; L+P) as frontline treatment for advanced renal cell ...

Updated long-term data from the phase 2/3 QUILT-3.032 trial (NCT03022825) continue to demonstrate promising outcomes for the IL-15 superagonist nogapendekin alfa inbakicept (NAI; Anktiva) in patients ...

The crosstalk between bile acid (BA) metabolism and the Hippo pathway plays a role in pathogenesis of liver diseases. Here the authors show that the transcriptional coactivator YAP exerts a ...

(UroToday.com) The 2025 AUA annual meeting featured an upper tract urothelial carcinoma session and a presentation by Dr. Jiwei Huang discussing results of a phase II study of tislelizumab as ...

The appearance of vulvar cancer will vary depending on the type. In general, signs of vulvar cancer can include moles, lumps, or bumps on the vulva, flakiness or thickening of the skin in that area, ...